The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/foc.3.1.14

Major depression is one of the most common psychiatric disorders, with lifetime prevalence rates of over 15%. Recent research provides new insights on which brain regions are affected in the disorder, underlying biological mechanisms, and possible novel treatments. This review discusses a number of recent research advances in epidemiology, genetics, imaging, treatment, and pharmacogenetics. It also outlines issues or questions that still need to be addressed, and it begins to outline a framework for understanding why and how depression may occur.